On May 29, 2018, pharmaceutical company Allergan announced the recall of nearly 170,000 packets of Taytulla birth control capsules. Allergan had distributed the contraceptives to doctors nationwide for use as free samples for patients. A manufacturing error caused the capsules to be placed out of…
Currently, Nuplazid (pimavanserin), marketed by Acadia Pharmaceuticals Inc., is the only medication approved by the FDA to treat the hallucinations and mental delusions associated with Parkinson’s disease psychosis. The FDA is now taking another look at the drug, however, after receiving reports of
Merck & Co., Inc., makers of the shingles vaccine Zostavax, recently filed a motion to transfer all Zostavax lawsuits to one court for coordinated pre-trial proceedings. There are currently nearly 60 lawsuits pending in Federal District courts around the country, involving plaintiffs who claim they…
On March 26, 2018, a Kentucky woman filed a new Onglyza lawsuit against manufacturers Bristol-Myers Squibb and AstraZeneca. She claims that after taking the type-2 diabetes drug, she suffered from serious injuries, and seeks compensation for her medical expenses and pain and suffering. The case…
On March 2, 2018, pharmaceutical companies Biogen and AbbVie announced the worldwide withdrawal of the drug Zinbryta (daclizumab), which is used to help treat multiple sclerosis (MS). In a related press release, the companies stated that the recall was “in the best interest of patients,”…
On March 1, 2018, an Arizona woman filed a new Jardiance lawsuit against manufacturers Boehringer Ingelheim, claiming the type 2 diabetes medication caused her to suffer from serious injuries. She filed the case in the U.S. District Court for the District of Arizona, and seeks…
In late February 2018, an Ohio woman, as representative of a male family member, filed a new Onglyza lawsuit in the U.S. District Court for the Southern District of Ohio. This case now joins a number of other similar cases filed by patients who took…
On January 23, 2018, a North Carolina woman filed a new Kombiglyze XR (saxagliptin and metformin) lawsuit against manufacturers Bristol-Myers Squibb and AstraZeneca. She claims that after taking the diabetes medication, she suffered serious injuries that required hospitalization. She filed her case
On January 9, 2018, an Illinois man filed a new Onglyza lawsuit in the U.S. District Court for the Central District of Illinois. He claims that after taking the diabetes medication, he suffered serious injuries. He seeks in excess of $75,000 in damages. Plaintiff Claims…
Tasigna (nilotinib) is a drug manufactured by Novartis to treat chronic myelogenous leukemia (CML). The FDA approved it for this use in 2007, but since then, there have been several studies that have linked the medication with an increased risk for atherosclerosis. In 2013, Health…
On January 28, 2018, the FDA alerted consumers and their healthcare providers to the fact that Primus Pharmaceuticals had implemented a recall of all Limbrel products due to rare but potentially serious health risks. Primus is notifying distributors and is arranging for the return of…
On February 2, 2018, the U.S. Judicial Panel on Multidistrict Litigation (“JPML” or “panel”) ordered that all federally-filed Onglyza (saxagliptin) lawsuits be centralized in the Eastern District of Kentucky. That means a total of 84 cases pending in over 26 districts will be transferred to…